GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a truly shift in how we treat diabetes mellitus . These new drugs work by mimicking the body’s natural GLP-1 substance , which https://45listing.com/story23914507/glp-1-a-major-advance-in-blood-sugar-treatment